Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 11 November 2015, there was an open day at the John Radcliffe Hospital for brain tumour patients and carers. The aim was to show what clinical researchers in Oxford are doing to improve diagnosis and care. The event was organised in partnership between the Nuffield Department of Clinical Neurosciences and the Cancer Research UK Oxford Centre, and was supported by the NIHR Oxford Biomedical Research Centre and the Brain Tumour Charity.

These sorts of events help to demystify medicine and I hope there'll be more of them. - Event attendee

Fifty people of a wide range of ages attended the day, which included tours of the Neuropathology Lab and the Oxford Centre for Functional MRI of the brain. Visitors had the chance to look down a microscope and discover how tissue is prepared for analysis, as well as talking to a neurosurgeon about how he performs operations, and seeing an MRI scanner in action.

This event built on a previous open day on 13 March 2015, when we gave 80 people ranging in age from 17 to 70 a tour of the facility. After an introductory talk about the importance of having a brain bank, attendees were divided into four groups for a laboratory tour, during which they had the opportunity to look down a microscope at a healthy and diseased human brain; see a real human brain; observe how tissue is prepared for analysis; and learn about research projects involving brain bank tissue.

Similar stories

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.